• 1
    Suhrbier A, La Linn M. Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses. Curr Opin Rheumatol 2004; 16: 3749.
  • 2
    Outbreak news. Chikungunya and dengue, south-west Indian Ocean. Wkly Epidemiol Rec 2006; 81: 1068.
  • 3
    Outbreak news. Chikungunya, India. Wkly Epidemiol Rec 2006; 81: 40910.
  • 4
    Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, et al. CHIKV study group. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007; 370: 18406.
  • 5
    Lanciotti RS, Ludwig ML, Rwaguma EB, Lutwama JJ, Kram TM, Karabatsos N, et al. Emergence of epidemic o'nyong-nyong fever in Uganda after a 35-year absence: genetic characterization of the virus. Virology 1998; 252: 25868.
  • 6
    Harley D, Sleigh A, Ritchie S. Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin Microbiol Rev 2001; 14: 90932.
  • 7
    Rulli N, Suhrbier A, Hueston L, Heise MT, Tupanceska D, Zaid A, et al. Ross River virus: molecular and cellular aspects of disease pathogenesis. Pharmacol Ther 2005; 107: 32942.
  • 8
    Fraser JR. Epidemic polyarthritis and Ross River virus disease. Clin Rheum Dis 1986; 12: 36988.
  • 9
    Mylonas AD, Brown AM, Carthew TL, McGrath B, Purdie DM, Pandeya N, et al. Natural history of Ross River virus-induced epidemic polyarthritis. Med J Aust 2002; 177: 35660.
  • 10
    Harley D, Bossingham D, Purdie DM, Pandeya N, Sleigh AC. Ross River virus disease in tropical Queensland: evolution of rheumatic manifestations in an inception cohort followed for six months. Med J Aust 2002; 77: 3525.
  • 11
    Morrison TE, Whitmore AC, Shabman RS, Lidbury BA, Mahalingam S, Heise MT. Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol 2006; 80: 73749.
  • 12
    Lidbury BA, Rulli NE, Suhrbier A, Smith PN, McColl SR, Cunningham AL, et al. Macrophage-derived pro-inflammatory factors contribute to the development of arthritis and myositis following infection with an arthrogenic alphavirus. J Infect Dis 2008; 197: 158593.
  • 13
    Lidbury BA, Simeonovic C, Maxwell GE, Marshall ID, Hapel AJ. Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. J Infect Dis 2000; 181: 2734.
  • 14
    Fraser JR, Cunningham AL, Clarris BJ, Aaskov JG, Leach R. Cytology of synovial effusions in epidemic polyarthritis. Aust N Z J Med 1981; 11: 16873.
  • 15
    Szekanecz Z, Koch AE. Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol 2007; 19: 28995.
  • 16
    Asquith DL, McInnes IB. Emerging cytokine targets in rheumatoid arthritis. Curr Opin Rheumatol 2007; 19: 24651.
  • 17
    Tak PP. Chemokine inhibition in inflammatory arthritis. Best Prac Res Clin Rheumatol 2006; 20: 92939.
  • 18
    Mateo L, La Linn M, McColl SR, Cross S, Gardner J, Suhrbier A. An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interleukin-8. Intervirology 2000; 43: 5560.
  • 19
    Guglielmotti A, D'Onofrio E, Coletta I, Aquilini L, Milanese C, Pinza M. Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-α production. Inflamm Res 2002; 51: 2528.
  • 20
    Guglielmotti A, Aquilini L, D'Onofrio E, Rosignoli MT, Milanese C, Pinza M. Bindarit prolongs survival and reduces renal damage in NZB/W lupus mice. Clin Exp Rheumatol 1998; 16: 14954.
  • 21
    Zoja C, Corna D, Benedetti G, Morigi M, Donadelli R, Guglielmotti A, et al. Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease. Kidney Int 1998; 53: 72634.
  • 22
    Bhatia M, Ramnath RD, Chevali L, Guglielmotti A. Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2005; 288: 125965.
  • 23
    Sironi M, Guglielmotti A, Polentarutti N, Fioretti F, Milanese C, Romano M, et al. A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1. Eur Cytokine Netw 1999; 10: 43742.
  • 24
    Teixeira CR, Teixeira MJ, Gomes RB, Santos CS, Andrade BB, Raffaele-Netto I, et al. Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2/monocyte chemoattractant protein-1 expression and macrophage recruitment. J Immunol 2005; 175: 834653.
  • 25
    Mirolo M, Fabbri M, Sironi M, Vecchi A, Guglielmotti A, Mangano G, et al. Impact of the anti-inflammatory agent bindarit on the chemokinome: selective inhibition of the monocyte chemotactic proteins. Eur Cytokine Netw 2008; 19: 11922.
  • 26
    Perico N, Benigni A, Remuzzi G. Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection. Nat Rev Drug Discov 2008; 7: 93653.
  • 27
    Kuhn RJ, Niesters HG, Hong Z, Strauss JH. Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus. Virology 1991; 182: 43041.
  • 28
    Gerlag DM, Ransone L, Tak PP. The effect of a T cell-specific NF-κB inhibitor on in vitro cytokine production and collagen-induced arthritis. J Immunol 2000; 165: 16528.
  • 29
    Zare F, Bokarewa M, Nenonen N, Bergstrom T, Alexopoulou L, Flavell RA, et al. Arthritogenic properties of double-stranded (viral) RNA. J Immunol 2004; 172: 565663.
  • 30
    Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J Clin Invest 2001; 107: 711.
  • 31
    Mylonas AD, Harley D, Purdie DM, Pandeya N, Vecchio PC, Farmer JF, et al. Corticosteroid therapy in an alphaviral arthritis. J Clin Rheumatol 2004; 10: 32630.
  • 32
    Dragomir E, Simionescu M. Monocyte chemoattractant protein-1—a major contributor to the inflammatory process associated with diabetes. Arch Physiol Biochem 2006; 112: 23944.
  • 33
    Dawson J, Miltz W, Mir AK, Wiessner C. Targeting monocyte chemoattractant protein-1 signalling in disease. Expert Opin Ther Targets 2003; 7: 3548.
  • 34
    Kalinowska A, Losy J. Investigational CC chemokine receptor 2 antagonists for the treatment of autoimmune diseases. Expert Opin Investig Drugs 2008; 17: 126779.
  • 35
    Brown CR, Blaho VA, Loiacono CM. Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2. J Immunol 2003; 171: 893901.
  • 36
    Erwig LP, Henson PM. Immunological consequences of apoptotic cell phagocytosis. Am J Pathol 2007; 171: 28.
  • 37
    Lidbury B, Mahalingam S. Specific ablation of antiviral genes in macrophages by antibody dependent enhancement of Ross River virus infection. J Virol 2000; 74: 837681.
  • 38
    Linn ML, Mateo L, Gardner J, Suhrbier A. Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages. J Virol 1998; 72: 514653.
  • 39
    Biswas SK, Sodhi A. In vitro activation of murine peritoneal macrophages by monocyte chemoattractant protein-1: up-regulation of CD11b, production of proinflammatory cytokines, and the signal transduction pathway. J Interferon Cytokine Res 2002; 22: 52738.
  • 40
    Ackermann C, Kavanaugh A. Tumor necrosis factor as a therapeutic target of rheumatologic disease. Expert Opin Ther Targets 2007; 11: 136984.
  • 41
    Amin AR, Attur M, Abramson SB. Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis. Curr Opin Rheumatol 1999; 11; 2029.
  • 42
    Yin W, Hasunuma T, Kobata T, Sumida T, Nishioka K. Synovial hyperplasia in HTLV-I associated arthropathy is induced by tumor necrosis factor α produced by HTLV-I infected CD68+ cells. J Rheumatol 2000; 27: 87481.
  • 43
    Lechner F, Vogt HR, Seow HF, Bertoni G, Cheevers WP, von Bodungen U, et al. Expression of cytokine mRNA in lentivirus-induced arthritis. Am J Pathol 1997; 151: 105365.
  • 44
    Kerr JR, Cunniffe VS, Kelleher P, Coats AJ, Mattey DL. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. J Med Virol 2004; 74: 14755.
  • 45
    Winthrop KL. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat Clin Pract Rheumatol 2006; 2: 60210.
  • 46
    Rahman MM, McFadden G. Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog 2006; 2: e4.
  • 47
    Berger RG, Raab-Traub N. Acute monoarthritis from infectious mononucleosis. Am J Med 1999; 107: 1778.
  • 48
    Wilkerson MJ, Davis WC, Baszler TV, Cheevers WP. Immunopathology of chronic lentivirus-induced arthritis. Am J Pathol 1995; 146: 143343.